glp 1 agonist new GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes GLP-1 receptor agonists show promise
Description
The trials also revealed non-inferior efficacy and a safety profile with that of the reference liraglutide
Adult neurogenesis is severely affected in PD, although the exact mechanisms and effects of these changes are not fully understood, there may be a dynamic interaction between them and PD-related pathology
Discovery of gastric inhibitory polypeptide and its subsequent fate: personal reflections
K.McleanB
Tau beats amyloid in predicting brain atrophy in Alzheimer disease: implications for prognosis and clinical trials
Endocr Connect (2017) 6(8):85665
